Loading...
Market
PorMedTec's GM pig kidney technology milestone by end of 2025?
2
Resolution / Starting Odds
Human clinical trials begin • 25%
Partnership with major healthcare provider • 25%
Patent granted for technology • 25%
No significant milestone achieved • 25%
Official reports or announcements from PorMedTec
Story
Japanese Startup Achieves First Genetically Modified Pig Kidney Transplant in Macaque for Clinical Application
Nov 25, 2024, 06:37 AM
A Japanese startup, PorMedTec, has successfully transplanted a genetically modified pig kidney into a crab-eating macaque, marking the first such procedure in Japan. This domestic first experiment aims to address the shortage of transplant organs and move towards clinical trials in humans. The kidney was modified to prevent rejection, and the macaque was able to urinate post-transplantation. The success of this experiment, conducted in collaboration with a university, is seen as a step towards establishing xenotransplantation technology for kidney disease patients.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
NYU Langone • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Other • 25%
Less than 5 • 25%
5 to 10 • 25%
11 to 20 • 25%
More than 20 • 25%
1-3 • 25%
4-6 • 25%
7-9 • 25%
10 or more • 25%
Yes • 50%
No • 50%
0-5 • 25%
6-10 • 25%
11-20 • 25%
More than 20 • 25%
Rejection issues • 25%
Infection complications • 25%
Ethical concerns • 25%
Other challenges • 25%
Yes • 50%
No • 50%